Literature DB >> 16538974

Acute renal failure and hypercalcemia.

Miguel Moysés-Neto1, Fabiana M Guimarães, Fátima H Ayoub, Osvaldo M Vieira-Neto, José Abrão C Costa, Márcio Dantas.   

Abstract

Hypercalcemia can result from excessive bone resorption, renal calcium retention, excessive intestinal calcium absorption, or a combination of these conditions. Hypercalcemia may also provoke acute renal failure (ARF) or hypertension, or aggravate the tubular necrosis that is frequently found in cases of ARF. The association of ARF and hypercalcemia was studied retrospectively in eight patients based in the data in their charts. Data are expressed as median and percentile (25th; 75th). Our results show that ARF associated with hypercalcemia was related with comorbidity in all cases (cancer, multiple myeloma, hyperparathyroidism, sarcoidosis, vitamin D intoxication, and leprosy). Maximum median serum creatinine levels were 3.3 mg/dL (2.7, 3.8 mg/dL) before treatment and 1.1 mg/dL (0.9, 1.3 mg/dL) after treatment. Maximum total median serum calcium was 15.9 mg/dL (13.5, 19.8 mg/dL) before treatment and 9.1 mg/dL (8.4, 9.7 mg/dL) after treatment. Maximum median ionized serum calcium was 2.1 mmol/L (1.8, 2.2 mmol/L) before treatment and 1.1 mmol/L (1.0, 1.2 mmol/L) after treatment. Different kinds of treatment induced a rapid fall in serum calcium concentration. All patients were treated with hydration and diuretics, and three patients also received calcitonin. Serum creatinine concentration always fell simultaneously with the decrease in serum calcium in all cases. All patients progressed with nonoliguric renal failure. In conclusion, in ARF, patients are frequently hypocalcemic. Usually, the presence of hypercalcemia associated with ARF is indicative of the presence of comorbidity, as observed in all eight patients studied here. There was an improvement of renal function in all cases as serum calcium levels decreased.

Entities:  

Mesh:

Year:  2006        PMID: 16538974     DOI: 10.1080/08860220500531005

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  12 in total

1.  Methotrexate-induced iatrogenic immunodeficiency-associated lymphoproliferative disorder causing hypercalcaemia.

Authors:  Monica Lee; Khoa Anh Nguyen; Robert Kaplan
Journal:  BMJ Case Rep       Date:  2019-05-31

2.  Not all ST-segment changes are myocardial injury: hypercalcaemia-induced ST-segment elevation.

Authors:  Adam Orville Strand; Thein Tun Aung; Ajay Agarwal
Journal:  BMJ Case Rep       Date:  2015-10-13

3.  Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients.

Authors:  Lee-Moay Lim; Hung-Tien Kuo; Mei-Chuan Kuo; Yi-Wen Chiu; Jia-Jung Lee; Shang-Jyh Hwang; Jer-Chia Tsai; Chi-Chih Hung; Hung-Chun Chen
Journal:  BMC Nephrol       Date:  2014-11-21       Impact factor: 2.388

4.  Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease.

Authors:  Tajda Keber; Martin Tretjak; Andreja Cokan Vujkovac; Marija Mravljak; Katja Ravber; Bojan Vujkovac
Journal:  Am J Case Rep       Date:  2017-06-09

5.  Impact of admission serum ionized calcium levels on risk of acute kidney injury in hospitalized patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Api Chewcharat; Michael A Mao; Tarun Bathini; Saraschandra Vallabhajosyula; Sorkko Thirunavukkarasu; Kianoush B Kashani
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

6.  Immobilization-Related Hypercalcemia in a COVID-19 Patient With Prolonged Intensive Care Unit Stay.

Authors:  Jean-Baptiste Mesland; Christine Collienne; Pierre-François Laterre; Philippe Hantson
Journal:  Am J Phys Med Rehabil       Date:  2022-01-01       Impact factor: 3.412

7.  Admission electrolyte and osmotic pressure levels are associated with the incidence of contrast-associated acute kidney injury.

Authors:  Qingbo Lv; Duanbin Li; Yao Wang; Pengcheng Yu; Liding Zhao; Songzan Chen; Min Wang; Guosheng Fu; Wenbin Zhang
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

8.  A modified method for reducing renal injury in zoledronic Acid treatment of hypercalcemia and adverse skeletal events.

Authors:  Jiang Liu; Liqun Zheng; Wenhua Zhang; Keli Chang; Yan Pang
Journal:  Indian J Palliat Care       Date:  2013-01

9.  Acute Kidney Injury Secondary to Necrotizing Sarcoid Granulomatosis.

Authors:  Varun Mamidi; Manikantan Shekar; Jaiju James Chakola; Vamsi Krishna Makkena; Jayakumar Matcha
Journal:  Case Rep Nephrol       Date:  2019-11-05

Review 10.  Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.

Authors:  Hsuan Yeh; Chung-Cheng Chiang; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.